Sintx Technologies (SINT) Total Non-Current Liabilities (2013 - 2026)
Sintx Technologies (SINT) posted Total Non-Current Liabilities of $6.4 million for Q1 2026, up 11.7% on a QoQ basis from $5.8 million in Q4 2025, and up 22.67% year-over-year from $5.2 million in Q1 2025.
Analysis
Sintx Technologies (SINT) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
Sintx Technologies has reported Total Non-Current Liabilities for 14 years, with the latest figure at $6.4 million in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities rose 22.67% year-over-year to $6.4 million in Q1 2026; TTM through Mar 2026 was $6.4 million, a 22.67% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 8.27% from the prior year.
- Total Non-Current Liabilities was $6.4 million for Q1 2026 at Sintx Technologies, up from $5.8 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $10.1 million in Q4 2022, with the low at $4.1 million in Q1 2022.
- Average Total Non-Current Liabilities over 5 years is $6.0 million, with a median of $5.7 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities jumped 134.23% in 2022, then sank 37.53% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $10.1 million in 2022, then tumbled by 37.53% to $6.3 million in 2023, then slipped by 15.55% to $5.3 million in 2024, then increased by 8.27% to $5.8 million in 2025, then grew by 11.7% to $6.4 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $6.4 million (Q1 2026), $5.8 million (Q4 2025), and $6.4 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 5.75 Mn |
| Sep 30, 2025 | 6.43 Mn |
| Jun 30, 2025 | 5.05 Mn |
| Mar 31, 2025 | 5.24 Mn |
| Dec 31, 2024 | 5.31 Mn |
| Sep 30, 2024 | 5.72 Mn |
| Jun 30, 2024 | 6.44 Mn |
| Mar 31, 2024 | 7.61 Mn |
| Dec 31, 2023 | 6.29 Mn |
| Sep 30, 2023 | 4.75 Mn |
| Jun 30, 2023 | 5.18 Mn |
| Mar 31, 2023 | 6.56 Mn |
| Dec 31, 2022 | 10.07 Mn |
| Sep 30, 2022 | 5.01 Mn |
| Jun 30, 2022 | 5.25 Mn |
| Mar 31, 2022 | 4.13 Mn |
| Dec 31, 2021 | 4.30 Mn |
| Sep 30, 2021 | 4.81 Mn |
| Jun 30, 2021 | 3.64 Mn |